high
throughput
assay
antisarscov
igg
antibodi
detect
need
largescal
epidemiolog
studi
perform
micropl
enzym
immunoassay
detectsar
tm
evalu
detect
antisarscov
igg
antibodi
assay
base
synthet
peptid
deriv
nucleocapsid
spike
protein
result
show
assay
provid
high
degre
sensit
convalesc
serum
sampl
level
specif
close
show
signific
variat
among
differ
control
group
high
degre
sensit
togeth
highthroughput
natur
make
advantag
screen
assay
studi
handl
larg
number
specimen
requir
novel
infect
result
sever
acut
respiratori
syndrom
sar
emerg
quangdong
provinc
southern
china
novemb
march
infect
spread
hong
kong
vietnam
singapor
toronto
taiwan
mani
citi
total
case
death
report
world
health
organ
worldwid
outbreak
halt
juli
world
health
organ
culprit
agent
new
coronaviru
sarscov
distinct
phylogenet
three
group
previou
known
coronavirus
kuiken
et
al
marra
et
al
peiri
et
al
poutanen
et
al
rota
et
al
improv
understand
novel
devast
human
infect
accur
diagnost
tool
indispens
present
avail
highthroughput
serolog
assay
sarscov
still
limit
remain
major
hindranc
largescal
epidemiolog
studi
evalu
commerci
assay
detectsar
tm
kit
adalti
italia
ce
mark
indirect
micropl
enzym
immunoassay
detect
antisarscov
immunoglobulin
ig
g
antibodi
human
serum
plasma
specimen
describ
nonsar
pneumonia
control
two
hundr
fifti
convalesc
serum
specimen
collect
patient
admit
princ
wale
hospit
fever
pneumonia
use
nonsar
pneumonia
control
pediatr
patient
age
year
mean
sd
girl
adult
age
year
mean
sd
femal
elderli
age
year
mean
sd
women
nonsar
healthi
control
two
hundr
serum
specimen
collect
medic
student
prevaricella
vaccin
check
use
nonsar
healthi
control
age
rang
year
mean
sd
femal
sar
group
sar
group
compris
sar
patient
age
year
mean
sd
femal
patient
present
acut
onset
fever
progress
pneumonia
otherwis
unexplain
seroconvers
fourfold
rise
antisarscov
igg
antibodi
titr
detect
immunofluoresc
assay
describ
previous
chan
et
al
patient
fulfil
unit
state
center
diseas
control
prevent
us
cdc
world
health
organ
criteria
sar
world
health
organ
center
diseas
control
prevent
convalesc
blood
sampl
collect
day
onset
ill
retriev
studi
addit
earli
blood
sampl
collect
day
onset
ill
avail
studi
detectsar
tm
kit
incorpor
synthet
peptid
deriv
epitop
nucleocapsid
spike
protein
sarscov
first
phase
develop
kit
amino
acid
sequenc
nucleocapsid
spike
protein
predict
publish
sequenc
sarscov
genbank
access
number
first
screen
region
show
high
indic
hydrophil
kyledoolittl
index
antigen
jamesonwolf
index
surfac
probabl
emini
index
result
deduc
peptid
synthes
chemic
use
fmoc
synthesi
peptid
coat
individu
micropl
evalu
sensit
specif
detect
antisarscov
igg
antibodi
panel
consist
specimen
collect
sarsconvalesc
patient
patient
affect
respiratori
diseas
healthi
donor
use
select
appropri
peptid
among
peptid
test
one
spike
peptid
close
nterminu
two
nucleocapsid
peptid
locat
respect
nand
cterminu
found
best
three
peptid
use
detectsar
tm
kit
studi
assay
procedur
carri
accord
detectsar
tm
kit
protocol
briefli
peptid
coat
micropl
allow
bind
sarscovspecif
antibodi
present
serum
specimen
wash
step
horseradish
peroxidaselabel
goat
antibodi
specif
human
igg
ad
antigenantibodi
complex
detect
enzym
substrat
ad
second
wash
step
result
interpret
accord
manufactur
criteria
express
index
valu
ratio
absorb
cutoff
valu
specimen
index
valu
regard
reactiv
antisarscov
igg
index
valu
retest
duplic
averag
index
valu
obtain
repeat
test
use
classifi
statu
specimen
specimen
averag
index
remain
regard
equivoc
inhous
indirect
immunofluoresc
assay
antisarscov
igg
base
virusinfect
cell
use
refer
studi
assay
shown
highli
sensit
specif
test
procedur
describ
previous
chan
et
al
nonsar
specimen
found
reactiv
found
equivoc
antisarscov
igg
antibodi
use
detectsar
tm
kit
tabl
specimen
test
neg
immunofluoresc
assay
indic
trueneg
specimen
proport
specimen
show
equivoc
result
rang
signific
differ
observ
among
variou
control
group
p
chisquar
test
specif
rang
signific
differ
observ
among
variou
control
group
p
chisquar
test
absorb
indic
sampl
test
shown
figur
major
falseposit
result
low
rang
indic
result
sar
group
shown
tabl
sensit
detectsar
tm
kit
detect
antisarscov
igg
antibodi
convalesc
specimen
collect
day
onset
ill
earli
serum
specimen
test
reactiv
absorb
indic
specimen
test
shown
figur
major
trueposit
result
high
rang
indic
posit
rate
accord
time
specimen
collect
shown
figur
result
studi
show
detectsar
tm
kit
high
degre
sensit
detect
antisarsigg
antibodi
convalesc
blood
specimen
case
specimen
collect
acut
phase
diseas
day
sensit
assay
increas
day
day
worth
note
number
similar
report
rtpcr
assay
appli
respiratori
specimen
peiri
et
al
chan
et
al
tang
et
al
sensit
detectsar
tm
kit
found
within
report
rang
enzym
immunoassay
base
purifi
virion
chen
et
al
whole
viral
lysat
tang
et
al
recombin
protein
guan
et
al
detectsar
tm
kit
also
provid
accept
specif
close
signific
differ
reactiv
rate
healthi
medic
student
pneumonia
patient
suggest
nonspecif
due
crossreact
pneumonia
pathogen
found
serum
specimen
collect
children
tend
higher
chanc
show
equivoc
nonspecif
reactiv
though
reach
statist
signific
observ
deserv
investig
specimen
found
reactiv
detectsar
tm
kit
confirm
anoth
assay
higher
specif
comparison
indirect
immunofluoresc
assay
detectsar
tm
kit
semiautom
micropl
format
allow
highthroughput
perform
featur
togeth
high
degre
sensit
make
advantag
epidemiolog
studi
handl
larg
number
specimen
requir
recent
studi
shown
immunodomin
epitop
spike
protein
locat
amino
acid
lu
et
al
nucleocapsid
protein
locat
amino
acid
chen
et
al
data
immunogen
sarscov
protein
would
use
improv
perform
serolog
assay
